Anti-GM-CSF Titer Predicts Response to GM-CSF Therapy in Pulmonary Alveolar Proteinosis
- 1 December 2002
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 105 (3), 342-350
- https://doi.org/10.1006/clim.2002.5301
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Our new understanding of pulmonary alveolar proteinosis: what an internist needs to know.Cleveland Clinic Journal of Medicine, 2001
- Pulmonary alveolar proteinosis: a complete response to GM-CSF therapyThorax, 2001
- Serological Diagnosis of Idiopathic Pulmonary Alveolar ProteinosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Exogenous Granulocyte–Macrophage Colony-Stimulating Factor Administration for Pulmonary Alveolar ProteinosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Rare diseases bullet 6: Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesisThorax, 2000
- Adenovirus-Mediated Granulocyte-Macrophage Colony-Stimulating Factor Improves Lung Pathology of Pulmonary Alveolar Proteinosis in Granulocyte-Macrophage Colony-Stimulating Factor-Deficient MiceHuman Gene Therapy, 1998
- Efficacy of Granulocyte–Macrophage Colony-Stimulating Factor in Acquired Alveolar ProteinosisNew England Journal of Medicine, 1996
- The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation.The Journal of Experimental Medicine, 1996
- Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.Proceedings of the National Academy of Sciences, 1994
- Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary HomeostasisScience, 1994